STRIDES PHARMA (longer term perspective)
Strides Pharma is in a re-accumulation phase on monthly charts. Even fundamentally its subsidiary is yet to get listed somewhere around 2022, organisation is going places
免责声明
这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。